COST vs PFE: Which Is the Better Buy?
Side-by-side comparison of Costco Wholesale Corporation and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-08.
Costco Wholesale Corporation · Consumer Defensive
$947.50
-1.4% upside to fair value
Grade C
High Quality
VS
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
QuantHub Verdict
PFE has more upside to fair value
(+2.8%).
PFE trades at a lower forward P/E
(19.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
COST |
PFE |
| Current Price |
$947.50 |
$25.22 |
| Fair Value Estimate |
$933.84 |
$25.92 |
| Upside to Fair Value |
-1.4%
|
+2.8%
|
| Market Cap |
$420.2B |
$143.7B |
| Forward P/E |
47.6x
|
19.2x
|
| EV / EBITDA |
28.3x
|
12.3x
|
| Price / Sales |
1.4x
|
2.3x
|
| Price / FCF |
47.7x
|
15.2x
|
| Revenue Growth YoY |
+11.6%
|
+5.4%
|
| Gross Margin |
12.9%
|
69.3%
|
| Operating Margin |
3.8%
|
23.4%
|
| Return on Equity |
28.3%
|
8.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.1%
|
6.6%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Costco Wholesale Corporation operates as a membership-only warehouse club offering a wide range of merchandise at low prices. The company exhibits high business quality with a durable competitive moat driven by cost advantages, strong brand loyalty, and efficient operations, reflected in a robust ROE of 28.3% and solid revenue growth of 11.6% in the most recent quarter. Despite these strengths, t…
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
Accumulation Zones
| Metric |
COST |
PFE |
| Zone Low |
$700.38 |
$19.44 |
| Zone High |
$793.76 |
$22.03 |
| In Buy Zone? |
No
|
No
|